IgE in childhood asthma: Relevance of demographic characteristics and polysensitisation

Archives of Disease in Childhood

Volumn 95, Issue 12, 2010, Pages 979-984

  Silvestri, M ^a   Pistorio, A ^a   Battistini, E ^a   Rossi, Giovanni A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; NITRIC OXIDE;

ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; EOSINOPHILIA; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

AGE FACTORS; ALLERGENS; ANIMALS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CHILD, PRESCHOOL; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MALE; NITRIC OXIDE; PYROGLYPHIDAE; VITAL CAPACITY;

EID: 78649902581     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.163667     Document Type: Article

References (38)

1. Bousquet J. Allergy as a global problem: 'think globally, act globally'. Allergy 2002;57:661-2.
2. Ownby DR. Clinical significance of immunoglobulin E. In: Middleton E Jr, Ellis EF, Yunginger JW, Reed CE, Adkinson NF, Busse WW, eds. Allergy principles and practice. 5th edn. St Louis, Missouri, USA: Mosby, Year Book, 1998:771-82
3. Jansen DF, Rijcken B, Schouten JP, et al. The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness. Am J Respir Crit Care Med 1999;159:924-31.
4. Sly PD, Boner AL, Björksten B, et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008;372:1100-6.
5. Wever-Hess J, Kouwenberg JM, Duiverman EJ, et al. Risk factors for exacerbations and hospital admissions in asthma of early childhood. Pediatr Pulmonol 2000;29:250-6.
6. Owen CE. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Pharmacol Ther 2007;113:121-33.
7. Rosenwasser LJ, Busse WW, Lizambri RG, et al. Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J Allergy Clin Immunol 2003;112:563-70.
8. Lanier B, Bridges T, Kulus M, et al. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. J Allergy Clin Immunol 2009;124:1210-6.
9. Carroll WD, Lenney W, Child F, et al. Asthma severity and atopy: how clear is the relationship? Arch Dis Child 2006;91:405-9.
10. Sacco O, Sale R, Silvestri M, et al. Total and allergen-specific IgE levels in serum reflect blood eosinophilia and fractional exhaled nitric oxide concentrations but not pulmonary functions in allergic asthmatic children sensitized to house dust mites. Pediatr Allergy Immunol 2003;14:475-81.
11. Takeda K, Shibasaki M, Takita H. Relation between bronchial responsiveness to methacholine and levels of IgE antibody against Dermatophagoides farinae and serum IgE in asthmatic children. Clin Exp Allergy 1993;23:450-4.
12. Le Souëf PN. Gene-environmental interaction in the development of atopic asthma: new developments. Curr Opin Allergy Clin Immunol 2009;9:123-7.
13. Klink M, Cline MG, Halonen M, et al. Problems in defining normal limits for serum IgE. J Allergy Clin Immunol 1990;85:440-4.
14. Taussig LM, Wright AL, Holberg CJ, et al. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol 2003;111:661-75; quiz 676.
15. Sherrill DL, Stein R, Halonen M, et al. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol 1999;104:28-36.
16. Baatenburg de Jong A, Dikkeschei LD, Brand PL. High prevalence of sensitization to aeroallergens in children 4 yrs of age or younger with symptoms of allergic disease. Pediatr Allergy Immunol 2009;20:735-40.
17. GINA. Global Strategy for Asthma Management and Prevention, updated 2006. http://www.ginasthma.org (accessed Oct 2008).
18. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
19. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160:2104-7.
20. Swinscow TDV. Correlation and regression. In: Swinscow TDV, Campbell MJ. eds. Statistics at square one. 9th edn. Southampton: BMJ Publishing Group, 1997:75-84.
21. Gatsonis C, Sampson AR. Multiple correlation: exact power and sample size calculations. Psychol Bull 1989;106:516-24.
22. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-22.
23. Jacobsen HP, Herskind AM, Nielsen BW, et al. IgE in unselected like-sexed monozygotic and dizygotic twins at birth and at 6 to 9 years of age: high but dissimilar genetic influence on IgE levels. J Allergy Clin Immunol 2001;107:659-63.
24. Ahmadi KR, Lanchbury JS, Reed P, et al. Novel association suggests multiple independent QTLs within chromosome 5q21-33 region control variation in total humans IgE levels. Genes Immun 2003;4:289-97.
25. Siroux V, Oryszczyn MP, Paty E, et al. Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study. Clin Exp Allergy 2003;33:746-51.
26. Kerkhof M, Dubois AE, Postma DS, et al. Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults. Allergy 2003;58:905-11.
27. Oliver JM, Kepley CL, Ortega E, et al. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcvarepsilonR1 signaling pathway. Immunopharmacology 2000;48:269-81.
28. Nahm DH, Kim HY, Park HS. House dust mite-specific IgE antibodies in induced sputum are associated with sputum eosinophilia in mite-sensitive asthmatics. Ann Allergy Asthma Immunol 2000;85:129-33.
29. Ricciardolo FL, Sterk PJ, Gaston B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004;84:731-65.
30. Mossalayi MD, Arock M, Debré P. CD23/Fc epsilon RII: signaling and clinical implication. Int Rev Immunol 1997;16:129-46.
31. Gilchrist M, McCauley SD, Befus AD. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 2004;104:462-9.
32. Silvestri M, Sabatini F, Spallarossa D, et al. Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma. Thorax 2001;56:857-62.
33. Gratziou C, Lignos M, Dassiou M, et al. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999;14:897-901.
34. Artlich A, Hagenah JU, Jonas S, et al. Exhaled nitric oxide in childhood asthma. Eur J Pediatr 1996;155:698-701.
35. Steerenberg PA, Janssen NA, de Meer G, et al. Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children. Thorax 2003;58:242-5.
36. Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9. (Pubitemid 28071253)
37. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999;159:69-73.
38. Barreto M, Villa MP, Martella S, et al. Exhaled nitric oxide in asthmatic and nonasthmatic children: influence of type of allergen sensitization and exposure to tobacco smoke. Pediatr Allergy Immunol 2001;12:247-56.